Semler Scientific (NASDAQ:SMLR) Shares Down 3.1% – Should You Sell?

Semler Scientific, Inc. (NASDAQ:SMLR) shares were down 3.1% on Thursday . The company traded as low as $67.62 and last traded at $69.08. Approximately 60,779 shares traded hands during trading, a decline of 80% from the average daily volume of 298,413 shares. The stock had previously closed at $71.28.

Semler Scientific Trading Up 0.8 %

The company’s 50-day simple moving average is $49.52 and its 200-day simple moving average is $36.68. The stock has a market capitalization of $666.11 million, a price-to-earnings ratio of 35.06 and a beta of 1.17.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.35. The business had revenue of $13.51 million during the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. State Street Corp lifted its holdings in Semler Scientific by 0.6% in the third quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after buying an additional 725 shares during the period. Quest Partners LLC lifted its stake in shares of Semler Scientific by 48.0% in the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after purchasing an additional 817 shares during the period. Newbridge Financial Services Group Inc. bought a new stake in shares of Semler Scientific during the 2nd quarter valued at about $34,000. US Bancorp DE grew its stake in Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after purchasing an additional 1,158 shares during the period. Finally, Rhumbline Advisers grew its stake in Semler Scientific by 27.1% during the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after purchasing an additional 1,320 shares during the period. Institutional investors and hedge funds own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.